Search results
AbbVie Beats Quarterly Views As Skyrizi Nearly Snags Humira's Title
Investor's Business Daily· 2 hours agoSkyrizi brought in $2.01 billion in sales, just barely trailing the $2.27 billion generated by the...
AbbVie lifts profit forecast after Skyrizi sales beat expectations
AOL· 2 hours ago(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street ...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 45 minutes ago"This is despite the significant increase in U.S. biosimilar market share in April," Leerink...
AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)
Seeking Alpha· 1 day agoAbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 17 minutes agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 4 hours agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
AbbVie Reports First-Quarter 2024 Financial Results
WPRI Providence· 4 hours ago...1 Percent on an Operational Basis, Due to Humira Biosimilar Competition; Global Humira Net Revenues Were $2.270 Billion; Global Skyrizi Net Revenues Were $2.008 Billion; Global Rinvoq Net Revenues Were $1.093 BillionFirst-Quarter Global Net Revenues from the ...
Tech Powers Stocks as Traders Look Beyond Data: Markets Wrap
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- Wall Street traders fearing another ultra-hot inflation report got a degree of relief...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 3 hours agoAbbVie stock was rising Friday after the biopharmaceutical company raised its full-year earnings...
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 4 hours agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
